PG Colon Course – Rocco Ricciardi
C. diff–27 sec https://www.ncbi.nlm.nih.gov/pubmed/15238490
https://www.ncbi.nlm.nih.gov/pubmed/?term=17638799
trend changes–2:24 https://www.ncbi.nlm.nih.gov/pubmed/?term=15116
Keyword(s): antibody response, bowel prep, C. diff colitis, CD, CDC, clinical severity score, CMS, community-acquired, cytotoxins, diarrhea, disease severity, donor stool, end ileostomy, enema, epidemic, Flagyl, fulminant pseudomembranous colitis, gastric acid-suppressive agents, hospital-acquired, IBD, immunoglobulins, lactate, laparoscopy, Malecot, Medicare reimbursement, mucous fistula, NGT, oral ABX, perf, peritonitis, quality measure, quinolones, recurrent, refractory, segmental CR resection, stool transplantations, subtotal colectomy, surgeon controlled risk factors, surgical disease, surgical tx, tcdC gene, total colectomy, toxic megacolon, toxin A, toxin gene-variant strain, toxinotype III, UC, vaccines, Vanco
Comments are closed.